JCR Pharmaceuticals to Present at the 21st Annual WORLDSymposium™ 2025 in San Diego JCR Pharmaceuticals Co., Ltd. (TSE 4552), a leading global specialty pharmaceutical company, has announced its participation in the 21st Annual WORLDSymposium™ 2025, which will take place from…
GeminiBio Appoints Matt Stober to Board of Directors Gemini Bioproducts, LLC (“GeminiBio”), a leading supplier of raw materials to the biopharmaceutical and advanced therapy industries, has announced the appointment of Matthew Stober to its Board of Directors. This strategic addition…
Sage Therapeutics Explores Strategic Alternatives and Rejects Biogen’s Acquisition Offer Sage Therapeutics, Inc. (Nasdaq: SAGE), a leader in brain health therapeutics, announced today that its Board of Directors has initiated a formal process to explore strategic alternatives for the company.…
Ncardia, a global leader in human induced pluripotent stem cell (hiPSC) technology, has officially launched the Ncyte® Heart in a Box, an innovative 3D model of cardiac microtissue designed to transform cardiovascular research and drug discovery. This groundbreaking system represents…
Arcus Biosciences Appoints Richard Markus, M.D., Ph.D., as Chief Medical Officer Arcus Bioscience a clinical-stage biopharmaceutical Officer company focused on developing novel molecules and combination therapies for cancer treatment, has announced the appointment of Richard Markus, M.D., Ph.D., as its…
Aseptic Filling Machine Market: Industry Trends and Global Forecasts to 2035 The global market for aseptic filling machines has witnessed remarkable growth over recent years, driven by advancements in pharmaceutical manufacturing processes, the increasing demand for biologics, and stringent regulations…
Global Survey Explores Public Sentiment on Breakthrough Technologies As Global Survey leaders convene for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) have launched one…
WuXi Biologics, delivered a keynote address at the 43rd J.P. Morgan Healthcare Conference, providing an insightful look into the company’s latest achievements, strategies, and future outlook. His presentation highlighted WuXi Biologics’ significant milestones and laid out an ambitious roadmap for…
Unprecedented challenges such as conflict, climate change, epidemics, and displacement are converging to create a severe global health crisis, leaving 305 million people in dire need of humanitarian assistance in 2025. To address these challenges, the World Health Organization (WHO)…
The Nomination Committee of Orion Corporation has provided its recommendations to the company’s Board of Directors regarding proposals for the 2025 Annual General Meeting (AGM). These recommendations address both the composition of the Board of Directors and their remuneration for…
Sarclisa Secures 1st Approval in China for Relapsed/Refractory Multiple Myeloma The National Medical Products Administration (NMPA) of China has granted approval for Sarclisa (isatuximab), an anti-CD38 monoclonal antibody, in combination with pomalidomide and dexamethasone (Pd) for the treatment of adult…
Eli Lilly and Company has announced its preliminary revenue guidance for 2024 and 2025, showcasing significant growth and momentum in its operations. For 2024, Lilly anticipates full-year worldwide revenue to reach approximately $45.0 billion, representing an impressive 32% growth compared…